 carcinoma endometrium histopathologic clinical study cases histopathologic review cases endometrial carcinoma undifferentiated carcinomas Forty-eight percent large cell type intermediate/small cell type tumors keratin Eleven tumors vimentin antibodies carcinoembryonic antigen antibodies neuron-specific enolase NSE antibodies bombesin beta-endorphin prealbumin synaptophysin mean age diagnosis years range crude survival Seventy-nine percent patients surgicopathologic Stage Stage II years intermediate/small cell types prognosis large cell type difference significant presence absence NSE vimentin immunoreactivity influence survival patients tumors half myometrium years contrast patients deep infiltrating tumors percent patients demonstrable vessel invasion years contrast affected